Biomedical Journal (Feb 2022)

Updates on the ketogenic diet therapy for pediatric epilepsy

  • Ara Ko,
  • Hye Eun Kwon,
  • Heung Dong Kim

Journal volume & issue
Vol. 45, no. 1
pp. 19 – 26

Abstract

Read online

The ketogenic diet (KD) is a high-fat, low-carbohydrate diet, in which fat, instead of glucose, acts as a major energy source through the production of ketone bodies. The KD was formally introduced in 1921 to mimic the biochemical changes associated with fasting and gained recognition as a potent treatment for pediatric epilepsy in the mid-1990s. Recent clinical and scientific knowledge supports the use of the KD in drug-resistant epilepsy patients for its anti-seizure efficacy, safety, and tolerability. The KD is also receiving growing attention as a potential treatment option for other neurological disorders. This article will review on the recent updates on the KD, focusing on its mechanisms of action, its alternatives, expansion on its use in terms of age groups and different regions in the world, and future issues.

Keywords